Table 5.
Distribution and Risk Assessment of DR with Different TIR Propotion
| TIR (%) | Normal N = 213 (%) | DR N = 332 | OR | 95% CI | |
|---|---|---|---|---|---|
| Background Stage n = 221 (%) | Proliferative Stage n = 89 (%) | ||||
| <20 | 5 (25.00%) | 7 (35.00%) | 8 (40.00%) | 3.843 | 1.010–4.613 |
| 20–40 | 19 (18.09%) | 48 (45.71%) | 38 (36.19%) | 1.571 | 0.837–2.332 |
| 40–60 | 43 (28.29%) | 75 (49.68%) | 33 (22.60%) | 1.183 | 0.418–1.921 |
| 60–80 | 89 (52.93%) | 57 (36.54%) | 19 (12.33%) | 0.585 | 0.293–0.804 |
| >80 | 56 (54.36%) | 36 (34.95%) | 11 (10.67%) | 0.485 | 0.429–0.966 |
Note: Data were expressed as n (%).
Abbreviations: DR, diabetic retinopathy; DPN, diabetic peripheral neuropathy; OR, odds ratio; 95% CI, 95% confidence interval; TIR, time in range.